FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years...
Actualidad
enfermedad de células falciformes
Un ensayo aleatorizado de fase 3 de Voxelotor en la enfermedad de células falciformes
Vichinsky E, Hoppe CC, Ataga KI, et al. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212 La...
La L-glutamina reduce consistentemente las crisis de células falciformes independientemente de la historia del dolor
Consistent Benefit of L-Glutamine Observed Across Patients With Low, Medium and High Number of Crises Reported in the Year Prior to Screening---Analysis From the Phase 3 Study of...
